While the global market for clinical trials in general maintains an upward trend, cancer death rates in the United States have declined, noted the company
AstraZeneca reported that it will invest $ 360 million in a new drug plant in Ireland. The company will establish a next-generation active pharmaceutical ingredient
Developed countries predominate in the list of the top 10 drug exporters in the world, eight of them European and with Germany at the fore.
While the global market for clinical trials in general maintains an upward trend, cancer death rates in the United States have declined, noted the company
AstraZeneca reported that it will invest $ 360 million in a new drug plant in Ireland. The company will establish a next-generation active pharmaceutical ingredient
Developed countries predominate in the list of the top 10 drug exporters in the world, eight of them European and with Germany at the fore.
